Search
for
Sort by
Research 601–630 of 643
- New Drugs: Eculizumab
- Alopecia in three women of southeast asian descent with chronic renal failure: Possible association with erythropoietin use
- Eczema-like, erythematous, infiltrated plaques: A common side effect of subcutaneous heparin therapy
- Topical imiquimod—Be aware of the unexpected
- A case of widespread actinic granuloma with associated drug-induced lupus erythematosus
- DRUG‐ASSOCIATED ALOPECIA
- Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Effect of Kuntai Capsule Combined with Nilestriol Tablets in the Treatment of Perimenopausal Syndrome and on Reproductive Hormones
- Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature
- Skin Penetration and Permeation Properties of Transcutol® in Complex Formulations
- Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- A Case of Rhupus with Rowell Syndrome
- Hair Growth After Gefitinib Treatment
- Alopecia areata
- Poster 148 Severe Hair Loss during Inpatient Rehabilitation due to Telogen Effluvium: A Case Report
- Queries and Minor Notes
- A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- The boosting effect of minoxidil 0.1% when combined with dutasteride 0.01% and microneedling in the treatment of female pattern hair loss
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males